deltatrials

Crohn disease Trials in Boston, United States

Conditions / Crohn disease / Boston, United States

Clinical trials for Crohn disease investigate a range of treatment strategies and patient populations.

29 total trials for this combination

Showing top 10 of 29 trials

Trials

NCT ID Title Status Phase
NCT00261976 A Long-term Safety Study of Infliximab (Remicade) COMPLETED
NCT03816345 Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO RECRUITING
NCT03656627 Nivolumab in Patients With Advanced Non-Small Cell Lung Cancer and Pre-existing Autoimmune Disease TERMINATED PHASE1
NCT07219537 A Study for Imaging the Lower Gastrointestinal Tract Using a Retro-TCE Capsule RECRUITING NA
NCT02596893 Efficacy and Safety Study of Mongersen (GED-0301) for the Treatment of Subjects With Active Crohn's Disease TERMINATED PHASE3
NCT00206700 Open-label Trial of Leukine in Active Crohn's Disease TERMINATED PHASE2
NCT04835506 Proactive Infliximab Optimization Using a Pharmacokinetic Dashboard Versus Standard of Care in Patients With Inflammatory Bowel Disease: The OPTIMIZE Trial ACTIVE_NOT_RECRUITING PHASE4
NCT03816345 Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO RECRUITING
NCT03782376 A Study to Evaluate Efficacy and Safety of Ustekinumab Re-induction Therapy in Participants With Moderately to Severely Active Crohn's Disease COMPLETED PHASE3
NCT07033208 Feasibility of a Wireless Thermal Capsule Endoscopy to Detect Gastrointestinal Thermal Variance RECRUITING NA

Related Pages